Diridavumab, CAS 1393659-46-5

Product Description: Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research of H2 influenza virus[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Sutton TC, et, al. In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice. J Virol. 2017 Nov 30;91(24):e01603-17.

CAS Number: 1393659-46-5

Molecular Weight: N/A

Compound Purity: 98.09

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Influenza Virus

• Artikelnummer: MEXHY-P99853-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99853-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated